3,217 results on '"Tamburino, Corrado"'
Search Results
302. 615 Characterization of actionable bleeding and thrombotic trade-offs in patients undergoing percutaneous coronary intervention
303. 735 Myocardial ischaemia: not just about obstructive coronary arteries
304. 90 Annular size and interaction with trans-catheter aortic valves for the treatment of severe bicuspid aortic valve stenosis: insights from the beat registry
305. 464 Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry
306. 806 Scout post-PCI instantaneous wave-free ratio as a driver of functional complete
307. 637 Real-world experience with the new watchman FLX device: data from two high volume sicilian centres. The FLX-iest registry
308. 807 Wellens syndrome: a rare entity not to underestimate
309. TCT-235 Annular Size and Its Interaction With Self-Expandable Versus Balloon-Expandable Transcatheter Heart Valves for the Treatment of Patients With Severe Bicuspid Aortic Valve Stenosis: Insights from the BEAT Registry
310. TCT-88 Relationship Between the Amount and Location of Macrophages and Clinical Outcome: Subanalysis of the CLIMA Study
311. Coronary artery cannulation after transcatheter aortic valve implantation
312. Characteristics and outcomes of MitraClip in octogenarians: Evidence from 1853 patients in the GIOTTO registry
313. Annular size and interaction with trans-catheter aortic valves for treatment of severe bicuspid aortic valve stenosis: Insights from the BEAT registry
314. TCT-238 Real-World Experience With the New Watchman FLX Device: Data From Two High-Volume Sicilian Centers: The FLX-IEST Registry
315. Impact of Post-Procedural Change in Left Ventricle Systolic Function on Survival after Percutaneous Edge-to-Edge Mitral Valve Repair
316. Polymer-free biolimus-A9-eluting stent performance according to renal impairment
317. An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
318. Early changes of left ventricular geometry and deformational analysis in obese subjects without cardiovascular risk factors: a three-dimensional and speckle tracking echocardiographic study
319. Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside
320. Early cardiovascular remodelling in Fabry disease
321. Reference Values for Real Time Three-Dimensional Echocardiography–Derived Left Ventricular Volumes and Ejection Fraction: Review and Meta-Analysis of Currently Available Studies
322. Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients
323. Local Delivery Versus Intracoronary Infusion of Abciximab in Patients With Acute Coronary Syndromes
324. Plaque Distribution Patterns in Distal Left Main Coronary Artery to Predict Outcomes After Stent Implantation
325. RENASCENT II: First in Human Evaluation of a Novel Sirolimus-Eluting Ultra-High Molecular Weight APTITUDE® Bioresorbable Scaffold: 9-and 24-Months Imaging and Clinical Results
326. Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry
327. Percutaneous aortic valve replacement in a 65-year old patient with thalassemia intermedia: A case report
328. Impact of Acute Coronary Syndromes on Two-Year Clinical Outcomes in Patients With Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents
329. Long-term outcomes after drug-eluting stent for the treatment of ostial left anterior descending coronary artery lesions
330. Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: Results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS)
331. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: Do we really need it?
332. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention
333. Ultrasound versus fluoroscopy-guided femoral access for percutaneous coronary intervention of chronic total occlusions: Insights from FOUND BLOOD CTO Registry
334. Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVI in Small Annuli - From TAVI FROM TAVI-SMALL Registry
335. Implantation of one, two or multiple MitraClips for transcatheter mitral valve repair: insights from a 1824-patient multicenter study
336. TCT-592 Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis
337. TCT-403 1-Year Clinical and Echocardiographic Outcomes of TAVI With the Latest SAPIEN 3 ULTRA Balloon-Expandable Valve: From the S3U Registry
338. TCT-232 Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes From a Subanalysis of the Delta 2 Registry
339. TCT-193 Extra-Mitral Valve Cardiac Involvement in Patients With Primary Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair
340. Usefulness of SYNTAX Score to Select Patients With Left Main Coronary Artery Disease to Be Treated With Coronary Artery Bypass Graft
341. Early discharge after transfemoral transcatheter aortic valve implantation
342. Multicenter evaluation of transcatheter aortic valve replacement using either SAPIEN XT or CoreValve: Degree of device oversizing by computed-tomography and clinical outcomes
343. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta-analysis of 5,971 patients
344. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis
345. Antiplatelet therapy following transcatheter aortic valve implantation
346. Ventricular arrhythmias in aortic valve stenosis before and after transcatheter aortic valve implantation
347. Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair
348. Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry
349. Gender-related clinical and echocardiographic outcomes at 30-day and 12-month follow up after MitraClip implantation in the GRASP registry
350. New Insights on Acute Expansion and Longitudinal Elongation of Bioresorbable Vascular Scaffolds In Vivo and At Bench Test: A Note of Caution on Reliance to Compliance Charts and Nominal Length
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.